AVBP

ArriVent BioPharma, Inc. Common Stock (AVBP)

US
$ 21.870.28%

Price Chart

Key Statistics

Market Cap
$ 727.02M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
156.11K
52W High
$ 36.37
52W Low
$ 15.47
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
19.4019
200-Day MA
24.8483
52 Week High
36.37
52 Week Low
15.47

About AVBP

ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancer.

Employees
52
Headquarters
Newtown Square, PA
CEO
Dr. Zhengbin Yao Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
CLF
Cleveland-Cliffs In...
$ 7.22
23.84
UAVS
AgEagle Aerial Syst...
$ 0.86
6.17
HP
Helmerich & Payne I...
$ 15.98
4.79
EXK
Endeavour Silver Co...
$ 3.75
3.88
CIVI
Civitas Resources I...
$ 28.45
3.87

Top Losers

Symbol/Name
LTP
% Chg
OKLO
Oklo Inc.
$ 50.07
-5.03
U
Unity Software Inc....
$ 25.54
-2.07
RDDT
Reddit Inc. Class A...
$ 109.91
-2.04
BANC
Banc of California ...
$ 13.50
-1.60
STM
STMicroelectronics ...
$ 24.64
-1.48